Zurich, 27 November 2018 – For the second consecutive year, UBS has been named Institutional Investor's Top Global Equity Research Firm, retaining the #1 spot in the annual ranking and having been in seventh place in 2013. The ranking, based on votes from buy-side analysts and portfolio managers, is a testament to the value that UBS analysts and its Research platform bring to clients globally.
Clients voted for their preferred research analysts and teams in each region. Together, this resulted in UBS holding 157 leading positions across the world, ranking well ahead of peers.
"We'd like to thank our clients for once again recognizing our top-rated analysts and the strength of our Equity Research offering through their votes,” said Juan Luis Perez, Group Head Research, UBS Evidence Lab and Data Analytics. “The results of the Institutional Investor survey underscores how effective our strategy and investments have been in creating a Research platform that is truly differentiated and invaluable to clients everywhere.”
“We are very proud of our analysts and grateful for our clients' continued recognition of the UBS method of question-driven, evidence-based research," said Barry Hurewitz, Global Head of UBS Evidence Lab Innovations and formerly Global Research COO. "We have the best analysts in the industry, and armed with resources such as UBS Evidence Lab, they are in the best position to identify the questions and create the research that has the greatest impact on investors."
Since its formation in 2014, UBS Research has published thousands of Evidence Lab reports. Across 45 specialized areas, UBS Evidence Lab experts harvest, cleanse and connect billions of data items each month.
The move of UBS Evidence Lab into the broader Investment Bank, from within the Research area, allows clients direct access to the same insight-ready datasets that UBS analysts use.
"We are now in prime position to take our offering to the next level,” said Perez. “With the power of our talent and UBS Evidence Lab, we’re confident in our ability to drive further momentum in Equity Research into 2019 and years to come."
UK: +44-207-567 47 14
Switzerland: +41-44-234 85 00
Americas: +1-212-882 58 57
APAC: +852-297-1 82 00